FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912352810> ?p ?o ?g. }

• W2912352810 endingPage "349" @default.
• W2912352810 startingPage "336" @default.
• W2912352810 abstract "In light of recently published guidelines from the US Food and Drug Administration (FDA) on the communication of real-world data (RWD) and real-world evidence (RWE) to support regulatory decision making, it is important to understand how such data are developed, the limitations of these data, and how to best use RWD to improve patient care. Historically, the use of RWE has been approached with skepticism because of its often-retrospective nature compared with data from conventional randomized controlled trials (RCTs). This review discusses the role and function of RWE and RWD in clinical research. We summarize the types of RWE used in clinical research, outline the challenges and limitations involved with these data, and suggest how these types of analyses can supplement results from clinical trials to foster a more complete understanding of a drug or disease area of interest. In particular, we focus on the role of RWE in investigating chronic myeloid leukemia (CML) and tyrosine kinase inhibitor therapy for CML.We reviewed FDA guidance on the use of RWE and conducted a PubMed literature search to evaluate published data from real-world studies in CML.RWE includes analysis of RWD gathered from nonconventional sources, including patient registries, observational studies, and social media, among others. Importantly, although real-world studies do not adhere to the same degree of controlled conditions and predefined patient-management strategies as do conventional clinical trials, analyses resulting from these studies can be held to a high degree of validation and standardization, making them as meaningful as those from RCTs. In CML, RWE has informed early treatment milestones and has provided a window into patient perspectives regarding treatment. These types of analyses have already informed and can continue to inform disease management. These improvements in disease management, in turn, will help clinicians to better forecast treatment challenges and allow for the optimization of future treatment paradigms.Real-world studies are different from conventional RCTs and therefore provide insight into distinct aspects of treatment and patient outcomes. Together with results from clinical trials, RWE can help to illustrate a more complete picture of the tolerability, effectiveness, and impact of a drug. The recently published guidelines indicate that the FDA expects a growing role for RWE." @default.
• W2912352810 created "2019-02-21" @default.
• W2912352810 creator A5012395020 @default.
• W2912352810 creator A5068544225 @default.
• W2912352810 date "2019-02-01" @default.
• W2912352810 modified "2023-10-16" @default.
• W2912352810 title "The Case for Real-world Evidence in the Future of Clinical Research on Chronic Myeloid Leukemia" @default.
• W2912352810 cites W1965243580 @default.
• W2912352810 cites W1991181074 @default.
• W2912352810 cites W1997101148 @default.
• W2912352810 cites W1999494567 @default.
• W2912352810 cites W2009129162 @default.
• W2912352810 cites W2011814974 @default.
• W2912352810 cites W2019633460 @default.
• W2912352810 cites W2022063341 @default.
• W2912352810 cites W2025681750 @default.
• W2912352810 cites W2028669471 @default.
• W2912352810 cites W2034463493 @default.
• W2912352810 cites W2034469570 @default.
• W2912352810 cites W2035899311 @default.
• W2912352810 cites W2041911861 @default.
• W2912352810 cites W2051421086 @default.
• W2912352810 cites W2055557358 @default.
• W2912352810 cites W2058924226 @default.
• W2912352810 cites W2061326496 @default.
• W2912352810 cites W2064370814 @default.
• W2912352810 cites W2064790183 @default.
• W2912352810 cites W2068508150 @default.
• W2912352810 cites W2074417541 @default.
• W2912352810 cites W2099747692 @default.
• W2912352810 cites W2105783133 @default.
• W2912352810 cites W2145480759 @default.
• W2912352810 cites W2147109509 @default.
• W2912352810 cites W2157450846 @default.
• W2912352810 cites W2166270808 @default.
• W2912352810 cites W2166647521 @default.
• W2912352810 cites W2234278652 @default.
• W2912352810 cites W2260921597 @default.
• W2912352810 cites W2313607879 @default.
• W2912352810 cites W2331849216 @default.
• W2912352810 cites W2333478622 @default.
• W2912352810 cites W2345930365 @default.
• W2912352810 cites W2397234997 @default.
• W2912352810 cites W2428296383 @default.
• W2912352810 cites W2473480037 @default.
• W2912352810 cites W2513126620 @default.
• W2912352810 cites W2515885770 @default.
• W2912352810 cites W2528188718 @default.
• W2912352810 cites W2560040996 @default.
• W2912352810 cites W2560688864 @default.
• W2912352810 cites W2589983700 @default.
• W2912352810 cites W2590307110 @default.
• W2912352810 cites W2597213291 @default.
• W2912352810 cites W2746041041 @default.
• W2912352810 cites W2766187515 @default.
• W2912352810 cites W2792384496 @default.
• W2912352810 cites W2793387867 @default.
• W2912352810 cites W2902818271 @default.
• W2912352810 cites W4294307875 @default.
• W2912352810 doi "https://doi.org/10.1016/j.clinthera.2018.12.013" @default.
• W2912352810 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30709609" @default.
• W2912352810 hasPublicationYear "2019" @default.
• W2912352810 type Work @default.
• W2912352810 sameAs 2912352810 @default.
• W2912352810 citedByCount "14" @default.
• W2912352810 countsByYear W29123528102019 @default.
• W2912352810 countsByYear W29123528102020 @default.
• W2912352810 countsByYear W29123528102021 @default.
• W2912352810 countsByYear W29123528102022 @default.
• W2912352810 countsByYear W29123528102023 @default.
• W2912352810 crossrefType "journal-article" @default.
• W2912352810 hasAuthorship W2912352810A5012395020 @default.
• W2912352810 hasAuthorship W2912352810A5068544225 @default.
• W2912352810 hasBestOaLocation W29123528101 @default.
• W2912352810 hasConcept C126322002 @default.
• W2912352810 hasConcept C142724271 @default.
• W2912352810 hasConcept C148482608 @default.
• W2912352810 hasConcept C168563851 @default.
• W2912352810 hasConcept C17744445 @default.
• W2912352810 hasConcept C177713679 @default.
• W2912352810 hasConcept C188087704 @default.
• W2912352810 hasConcept C199539241 @default.
• W2912352810 hasConcept C23131810 @default.
• W2912352810 hasConcept C2778729363 @default.
• W2912352810 hasConcept C2779134260 @default.
• W2912352810 hasConcept C535046627 @default.
• W2912352810 hasConcept C71924100 @default.
• W2912352810 hasConceptScore W2912352810C126322002 @default.
• W2912352810 hasConceptScore W2912352810C142724271 @default.
• W2912352810 hasConceptScore W2912352810C148482608 @default.
• W2912352810 hasConceptScore W2912352810C168563851 @default.
• W2912352810 hasConceptScore W2912352810C17744445 @default.
• W2912352810 hasConceptScore W2912352810C177713679 @default.
• W2912352810 hasConceptScore W2912352810C188087704 @default.
• W2912352810 hasConceptScore W2912352810C199539241 @default.
• W2912352810 hasConceptScore W2912352810C23131810 @default.
• W2912352810 hasConceptScore W2912352810C2778729363 @default.
• W2912352810 hasConceptScore W2912352810C2779134260 @default.

• next